Form 8K Transcode Therapeutics Inc For: 3 March
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Transcode Therapeutics Inc (RNAZ)
Transcode Therapeutics Inc stock price live, this page displays NASDAQ RNAZ stock exchange data. View the RNAZ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Transcode Therapeutics Inc real time stock price chart below.
What Is the Transcode Therapeutics Inc Stock Price Today?
The Transcode Therapeutics Inc stock price today is 9.6000.
What Is the Stock Symbol for Transcode Therapeutics Inc?
The stock ticker symbol for Transcode Therapeutics Inc is RNAZ.
Is RNAZ the Same as $RNAZ?
$RNAZ is a common way to refer to the Transcode Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Transcode Therapeutics Inc Trade On?
Transcode Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Transcode Therapeutics Inc a Good Stock to Buy?
Determining whether Transcode Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Transcode Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RNAZ quote. (ISIN: US89357L5012)
What Is the Transcode Therapeutics Inc Stock Price Today?
The Transcode Therapeutics Inc stock price today is 9.6000.
What Is the Stock Symbol for Transcode Therapeutics Inc?
The stock ticker symbol for Transcode Therapeutics Inc is RNAZ.
Is RNAZ the Same as $RNAZ?
$RNAZ is a common way to refer to the Transcode Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Transcode Therapeutics Inc Trade On?
Transcode Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Transcode Therapeutics Inc a Good Stock to Buy?
Determining whether Transcode Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Transcode Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RNAZ quote. (ISIN: US89357L5012)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.1089
10.0306
52 wk Range
6.0829
46.7600
RNAZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.108910.0306
52 wk Range
6.082946.7600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RNAZ Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K Transcode Therapeutics Inc For: 3 March
- Investing.com
- Form 8K Transcode Therapeutics Inc For: 23 February
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Transcode Therapeutics Inc Company Profile
TransCode Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer. The company’s lead therapeutic candidate comprises TTX-MC138 that targets microRNA-10b, a master regulator of metastatic cell viability in various cancers comprising breast, pancreatic, ovarian, colon cancer, glioblastomas, and others. Its preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1 and two indication agnostic programs; TTX-RIGA, an RNA- based agonist of the retinoic acid-inducible gene I targeting activation of innate immunity in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9-based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines that activate cytotoxic immune responses against tumor cells. TransCode Therapeutics, Inc. has strategic collaboration agreement with The University of Texas M. D. Anderson Cancer Center. The company was incorporated in 2016 and is based in Boston, Massachusetts.
Compare RNAZ to Peers and Sector
Metrics to compare | RNAZ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRNAZPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −7.4x | −0.5x | |
PEG Ratio | - | −0.20 | 0.00 | |
Price / Book | 6.2x | 3.1x | 2.6x | |
Price / LTM Sales | - | 115.1x | 3.2x | |
Upside (Analyst Target) | - | 41.3% | 51.4% | |
Fair Value Upside | Unlock | −11.4% | 8.5% | Unlock |
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
-5.82 / -1.02
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Transcode Therapeutics (RNAZ) Stock Price Today?
The Transcode Therapeutics stock price today is 9.6000 USD.
What Stock Exchange Does Transcode Therapeutics Trade On?
Transcode Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Transcode Therapeutics?
The stock symbol for Transcode Therapeutics is "RNAZ."
What Is the Transcode Therapeutics Market Cap?
As of today, Transcode Therapeutics market cap is 8.8000M USD.
What Is Transcode Therapeutics's Earnings Per Share (TTM)?
The Transcode Therapeutics EPS (TTM) is -58.1158.
From a Technical Analysis Perspective, Is RNAZ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Transcode Therapeutics Stock Split?
Transcode Therapeutics has split 4 times.
How Many Employees Does Transcode Therapeutics Have?
Transcode Therapeutics has 7 employees.
What is the current trading status of Transcode Therapeutics (RNAZ)?
As of Mar 07, 2026, Transcode Therapeutics (RNAZ) is trading at a price of 9.6000 USD, with a previous close of 9.3300 USD. The stock has fluctuated within a day range of 9.1089 USD to 10.0306 USD, while its 52-week range spans from 6.0829 USD to 46.7600 USD.
What Is the RNAZ Premarket Price?
RNAZ's last pre-market stock price is 9.6800 USD. The pre-market share volume is 40.0000, and the stock has decreased by 0.3500, or 3.7500%.
What Is the RNAZ After Hours Price?
RNAZ's last after hours stock price is 9.7800 USD, the stock has decreased by 0.1800, or 1.8800%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.